All Stories

  1. Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice
  2. Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial
  3. Epigenetic Age Acceleration in Adolescence Associates With BMI, Inflammation, and Risk Score for Middle Age Cardiovascular Disease
  4. Evaluation of biomarkers of kidney injury following 4% succinylated gelatin and 6% hydroxyethyl starch 130/0.4 administration in a canine hemorrhagic shock model
  5. Relationship between pulse pressure and inflammation with left ventricular diastolic dysfunction in chronic kidney disease patients
  6. Relationship Between Vitamin D Status From Childhood to Early Adulthood With Body Composition in Young Australian Adults
  7. Differential SLC6A4 methylation: a predictive epigenetic marker of adiposity from birth to adulthood
  8. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age
  9. Age at menarche and childhood body mass index as predictors of cardio-metabolic risk in young adulthood: A prospective cohort study
  10. Antiemetic doses of dexamethasone and their effects on immune cell populations and plasma mediators of inflammation resolution in healthy volunteers
  11. Association of maternal prenatal smoking GFI1-locus and cardio-metabolic phenotypes in 18,212 adults
  12. Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
  13. F2-isoprostanes affect macrophage migration and CSF-1 signalling
  14. Maternal smoking and low family income during pregnancy as predictors of the relationship between depression and adiposity in young adults
  15. Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  16. Cardiometabolic Risk Factors at 5 Years After Omega-3 Fatty Acid Supplementation in Infancy
  17. The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus
  18. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease
  19. Reprint of: Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease
  20. Dietary patterns, body mass index and inflammation: Pathways to depression and mental health problems in adolescents
  21. Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review
  22. Working (longer than) 9 to 5: are there cardiometabolic health risks for young Australian workers who report longer than 38-h working weeks?
  23. GC-MS Analysis of Lipid Oxidation Products in Blood, Urine, and Tissue Samples
  24. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
  25. Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans
  26. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial
  27. The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled
  28. Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents
  29. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial
  30. Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease
  31. FATNESS AND FITNESS WITH CARDIO-METABOLIC RISK FACTORS IN ADOLESCENTS
  32. Relationships between depression and anxiety symptoms scores and blood pressure in young adults
  33. Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
  34. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents
  35. A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men
  36. Early Life Factors, Obesity Risk, and the Metabolome of Young Adults
  37. Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults
  38. Does Furosemide Increase Oxidative Stress in Acute Kidney Injury?
  39. Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis
  40. Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy
  41. Effects of muscle strength and endurance on blood pressure and related cardiometabolic risk factors from childhood to adolescence
  42. F2-Isoprostanes in HDL are bound to neutral lipids and phospholipids
  43. Authors' reply re: Associations of maternal prepregnancy body mass index and gestational weight gain with cardio-metabolic risk factors in adolescent offspring: a prospective cohort study
  44. Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury
  45. Dual Energy X-Ray Absorptiometry Compared with Anthropometry in Relation to Cardio-Metabolic Risk Factors in a Young Adult Population: Is the ‘Gold Standard’ Tarnished?
  46. Prenatal omega-3 fatty acid supplementation does not affect offspring telomere length and F2-isoprostanes at 12 years: A double blind, randomized controlled trial
  47. Neglecting legumes has compromised human health and sustainable food production
  48. Controlled moderate hypovolaemia in healthy volunteers is not associated with the development of oxidative stress assessed by plasma F2-isoprostanes and isofurans
  49. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys
  50. Serum 25-hydroxyvitamin D concentrations and cardiometabolic risk factors in adolescents and young adults
  51. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease
  52. Hypothalamic-pituitary-adrenal axis activity under resting conditions and cardiovascular risk factors in adolescents
  53. Specialised pro-resolving mediators of inflammation in inflammatory arthritis
  54. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease
  55. Lipidomics Reveals Associations of Phospholipids With Obesity and Insulin Resistance in Young Adults
  56. Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening?
  57. The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes
  58. n-3 Fatty acid supplementation and proresolving mediators of inflammation
  59. Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
  60. Regular Fat and Reduced Fat Dairy Products Show Similar Associations with Markers of Adolescent Cardiometabolic Health
  61. Fish oil and multivitamin supplementation reduces oxidative stress but not inflammation in healthy older adults: A randomised controlled trial
  62. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n–3 fatty acids and aspirin
  63. Associations of maternal prepregnancy body mass index and gestational weight gain with cardio-metabolic risk factors in adolescent offspring: a prospective cohort study
  64. Randomized Controlled Intervention of the Effects of Alcohol on Blood Pressure in Premenopausal Women
  65. n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease
  66. Novel relationships between B12, folate and markers of inflammation, oxidative stress and NAD(H) levels, systemically and in the CNS of a healthy human cohort
  67. Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease
  68. Identification of a dietary pattern associated with greater cardiometabolic risk in adolescence
  69. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications
  70. Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: insights from a 20-year prospective follow-up birth cohort
  71. Use of the Dietary Guideline Index to assess cardiometabolic risk in adolescents
  72. An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
  73. Authors’ Response
  74. Contrasting effects of prenatal life stress on blood pressure and body mass index in young adults
  75. The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial
  76. Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats
  77. Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the Sun Exposure and Vitamin D Supplementation (SEDS) Study
  78. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors
  79. Lifecourse Adiposity and Blood Pressure Between Birth and 17 Years Old
  80. Effects of omega-3 and omega-6 fatty acids on human placental cytokine production
  81. Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents
  82. Higher breakfast glycaemic load is associated with increased metabolic syndrome risk, including lower HDL-cholesterol concentrations and increased TAG concentrations, in adolescent girls
  83. Supplementation with N-3 Long-Chain Polyunsaturated Fatty Acids or Olive Oil in Men and Women with Renal Disease Induces Differential Changes in the DNA Methylation of FADS2 and ELOVL5 in Peripheral Blood Mononuclear Cells
  84. Microparticles Mediate Hepatic Ischemia-Reperfusion Injury and Are the Targets of Diannexin (ASP8597)
  85. Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation
  86. Dairy product consumption, dietary nutrient and energy density and associations with obesity in Australian adolescents
  87. Vitamin D status and predictors of serum 25-hydroxyvitamin D concentrations in Western Australian adolescents
  88. The Comparison of Methods for Measuring Oxidative Stress in Zebrafish Brains
  89. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity
  90. Lower Fructose Intake May Help Protect Against Development of Nonalcoholic Fatty Liver in Adolescents With Obesity
  91. Preeclampsia and cardiovascular disease share genetic risk factors on chromosome 2q22
  92. Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage
  93. Fish Oil (SMOFlipid) and Olive Oil Lipid (Clinoleic) in Very Preterm Neonates
  94. Endothelial cationic amino acid transporter-1 overexpression can prevent oxidative stress and increases in arterial pressure in response to superoxide dismutase inhibition in mice
  95. Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age in Cerebrospinal Fluid
  96. Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors
  97. Early Infant Feeding and Adiposity Risk: From Infancy to Adulthood
  98. Rescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat
  99. Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+ are linked to differences in plasma carotenoid concentrations
  100. Monoamine oxidase a gene polymorphisms common to blood pressure and depression scores in caucasian children
  101. Obesity, Metabolic Syndrome and Nutrition
  102. Isoprostanes and neuroprostanes: Total synthesis, biological activity and biomarkers of oxidative stress in humans
  103. Low vitamin D levels are associated with symptoms of depression in young adult males
  104. Echium oil is better than rapeseed oil in improving the response of barramundi to a disease challenge
  105. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial
  106. Dietary n-3 PUFA and CVD: a review of the evidence
  107. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents
  108. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults
  109. Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta
  110. Prospective associations between sugar-sweetened beverage intakes and cardiometabolic risk factors in adolescents
  111. Gender Difference in the Relationship between Passive Smoking Exposure and HDL-Cholesterol Levels in Late Adolescence
  112. The Western Dietary Pattern Is Prospectively Associated With Nonalcoholic Fatty Liver Disease in Adolescence
  113. Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease
  114. Maternal Dietary Omega-3 Fatty Acid Supplementation Reduces Placental Oxidative Stress and Increases Fetal and Placental Growth in the Rat
  115. Dietary intake in population-based adolescents: support for a relationship between eating disorder symptoms, low fatty acid intake and depressive symptoms
  116. Low intake of B-vitamins is associated with poor adolescent mental health and behaviour
  117. Changes in Dairy Food and Nutrient Intakes in Australian Adolescents
  118. Early life programming of cardiometabolic disease in the Western Australian pregnancy cohort (Raine) study
  119. Dietary fructose in relation to blood pressure and serum uric acid in adolescent boys and girls
  120. Pre-pregnancy maternal overweight and obesity increase the risk for affective disorders in offspring
  121. Postnatal Fish Oil Supplementation in High-Risk Infants to Prevent Allergy: Randomized Controlled Trial
  122. 976 20-HETE IS ELEVATED IN PLASMA AND ASSOCIATES WITH RAISED BLOOD PRESSURE IN PREECLAMPSIA
  123. Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity
  124. Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid Supplementation
  125. Fish oil supplementation in early infancy modulates developing infant immune responses
  126. Oral contraceptive use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence
  127. Allergic disease in the first year of life is associated with differences in subsequent neurodevelopment and behaviour
  128. Sex Dimorphism in the Relation between Early Adiposity and Cardiometabolic Risk in Adolescents
  129. Reduced metal ion concentrations in atherosclerotic plaques from subjects with Type 2 diabetes mellitus
  130. Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans
  131. Associations between anxious-depressed symptoms and cardiovascular risk factors in a longitudinal childhood study
  132. Associations between aggressive behaviour scores and cardiovascular risk factors in childhood
  133. Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation–Myocardial Infarction
  134. The BACE1-PSEN-AβPP Regulatory Axis has an Ancient Role in Response to Low Oxygen/Oxidative Stress
  135. Is There a Role for Isofurans and Neuroprostanes in Pre-Eclampsia and Normal Pregnancy?
  136. Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls
  137. Are Isofurans and Neuroprostanes Increased After Subarachnoid Hemorrhage and Traumatic Brain Injury?
  138. Loci affecting gamma-glutamyl transferase in adults and adolescents show age × SNP interaction and cardiometabolic disease associations
  139. Omega 3 Fatty Acid Supplements and Cardiovascular Health: Commentary on the article by de Jong et al. on page 411
  140. Differential relationships between anthropometry measures and cardiovascular risk factors in boys and girls
  141. Dietary intake of omega-3 fatty acids and risk of depressive symptoms in adolescents
  142. Association of Genetic Loci With Glucose Levels in Childhood and Adolescence: A Meta-Analysis of Over 6,000 Children
  143. Polyunsaturated fatty acid intake and blood pressure in adolescents
  144. Recent advances in understanding the role and use of marine ω3 polyunsaturated fatty acids in cardiovascular protection
  145. Dietary intake and food sources of fatty acids in Australian adolescents
  146. Effects of lupin-enriched foods on body composition and cardiovascular disease risk factors: a 12-month randomized controlled weight loss trial
  147. Coenzyme Q10 and Statin Myalgia: What is the Evidence?
  148. A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates
  149. Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils
  150. Dietary Fats and Blood Pressure
  151. INTRODUCTION
  152. Omega-3 fatty acids and inflammation
  153. Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation
  154. Macronutrients. Fiber, Cholesterol and Dietary Patterns
  155. Dietary W3 Fatty Acids
  156. Dietary W3 Fatty Acids
  157. Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration
  158. Recent Developments Concerning Diet And Hypertension
  159. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans
  160. Study of Plasma Factors Associated With Neutrophil Activation and Lipid Peroxidation in Preeclampsia
  161. Dietary Cosupplementation With Vitamin E and Coenzyme Q 10 Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice
  162. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects
  163. Advanced glycation end-products: a review
  164. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction
  165. Non Pharmacologic Therapy and Lifestyle Factors in Hypertension
  166. Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Vascular Reactivity of the Forearm Microcirculation in Hyperlipidemic, Overweight Men
  167. Effect of ω3 fatty acids on oxidative stress in humans: GC–MS measurement of urinary F2-isoprostane excretion
  168. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non—insulin-dependent diabetic patients
  169. Fish oils, dyslipidaemia and glycaemic control in diabetes
  170. Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans
  171. Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry
  172. Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure
  173. Comparison of the effects of black and green tea onin vitro lipoprotein oxidation in human serum
  174. An Improved Method for the Measurement of Urinary and Plasma F2-Isoprostanes Using Gas Chromatography–Mass Spectrometry
  175. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels A randomized controlled trial
  176. Effects of Dietary Fish and Weight Reduction on Ambulatory Blood Pressure in Overweight Hypertensives
  177. The Independent and Combined Effects of Aerobic Exercise and Dietary Fish Intake on Serum Lipids and Glycemic Control in NIDDM: A randomized controlled study
  178. Interactions Between Dietary Fat, Fish, and Fish Oils and Their Effects on Platelet Function in Men at Risk of Cardiovascular Disease
  179. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum
  180. Analysis of native and oxidized low-density lipoprotein oxysterols using gas chromatography—mass spectrometry with selective ion monitoring
  181. Absence of increased susceptibility of LDL to oxidation in type 1 diabetics
  182. EFFECTS OF GARLIC EXTRACT ON PLATELET AGGREGATION: A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY
  183. Erratum. New Cembrene Diterpenes from the Resins of Eremophila Species
  184. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease
  185. New Cembrene Diterpenes from the Resins of Eremophila Species
  186. Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease.
  187. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation
  188. Differential Effect of Aspirin on Platelet Aggregation in IDDM
  189. URINARY STEROID PROFILES AND ALOCHOL-RELATED BLOOD PRESSURE ELEVATION
  190. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics
  191. Fish Oil-Induced Changes in Apolipoproteins in IDDM Subjects
  192. Dietary fish oils increase serum lipids in insulin-dependent diabetics compared with healthy controls
  193. Sesquiterpenes from Laurencia spp.
  194. SERUM LIPIDS IN INSULIN-DEPENDENT DIABETICS ARE MARKEDLY ALTERED BY DIETARY FISH OILS
  195. New findings in the fatty acid composition of individual platelet phospholipids in man after dietary fish oil supplementation
  196. The Chemistry of Eremophila Spp. XXV. New Cembrene Derivatives From E. dempsteri, E. platycalyx and E. fraseri
  197. A new class of macrocyclic diterpenes from (euphorbiaceae)
  198. The Chemistry of Eremophila spp. XX. The Absolute Stereochemistry of the Viscidane Diterpenes
  199. The chemistry of Eremophila spp. XXI. Structural study of a new eremane diterpene
  200. The chemistry of Eremophila spp. XIX. New cembrane diterpenes from E. granitica and E. abietina